Patent · US Expired

Nanoparticulate megestrol formulations

US7101576B2 · kind B2 · utility

56Cited by
77References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 14, 2003
Grant dateSep 5, 2006
Priority date
Expiry dateApr 22, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.